- Investing Ideas
- /
- Global High Growth Potential Companies
Global High Growth Potential Companies
Results
8705
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
8,705 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
RMDA | ج.م3.50 | -4.4% | 127.4% | ج.م5.3b | ج.م4.23 | PE23.2x | E30.2% | 1.9% | Pharmaceuticals & Biotech | ||
AXSM | US$92.45 | 1.6% | 54.0% | US$4.5b | US$129.41 | PS13.2x | E72.4% | n/a | Pharmaceuticals & Biotech | ||
PHM | €73.45 | -9.0% | 95.9% | €1.3b | €84.60 | PE2071.1x | E56.4% | 0.9% | Pharmaceuticals & Biotech | ||
ALKT | US$36.49 | -3.1% | 59.3% | US$3.6b | US$44.30 | PS11.6x | E98.6% | n/a | Software | ||
ACE | SEK 2.76 | 4.2% | -4.7% | SEK 265.2m | SEK 8.25 | PB2.5x | E47.2% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$167.43 | -2.3% | 54.5% | US$52.3b | US$174.38 | PE78.2x | E46.3% | 2.2% | Diversified Financials | ||
NEWBRY | SEK 3.68 | -7.5% | 1.1% | SEK 89.3m | SEK 8.00 | PS2.4x | E130.0% | n/a | Pharmaceuticals & Biotech | ||
ZVRA | US$8.60 | -4.0% | 92.0% | US$460.1m | US$20.00 | PS18.7x | E73.4% | n/a | Pharmaceuticals & Biotech | ||
ONON | US$51.49 | -2.3% | 80.9% | US$16.6b | US$58.60 | PE116.2x | E29.7% | n/a | Consumer Durables | ||
RHM | €582.40 | 3.1% | 108.9% | €25.3b | €642.07 | PE36.9x | E28.7% | 1.0% | Capital Goods | ||
TVTX | US$17.39 | -8.6% | 202.4% | US$1.5b | US$27.00 | PS7.4x | E72.4% | n/a | Pharmaceuticals & Biotech | ||
GAU | CA$2.03 | 4.6% | 144.6% | CA$516.4m | CA$3.51 | PS2.2x | E89.2% | n/a | Materials | ||
TGTX | US$29.61 | -3.7% | 131.0% | US$4.2b | US$37.22 | PS16x | E56.5% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$38.39 | 5.6% | 282.4% | CA$1.3b | n/a | PE21.7x | E37.6% | 1.5% | Diversified Financials | ||
ICOP | €7.32 | 1.4% | n/a | €202.3m | €9.30 | PE40x | E49.2% | n/a | Capital Goods | ||
AGP | €7.14 | 3.5% | 42.2% | €123.6m | €12.85 | PE18.3x | E22.1% | n/a | Capital Goods | ||
MBTN | CHF 0.50 | -52.8% | -99.7% | CHF 15.5m | CHF 6.03 | PS0.2x | E111.6% | n/a | Semiconductors | ||
NVG | zł1.64 | -3.5% | -15.0% | zł57.4m | zł3.65 | PE211.9x | E41.3% | 3.7% | Diversified Financials | ||
FWRY | ج.م8.35 | -0.7% | 65.3% | ج.م28.4b | ج.م11.39 | PE29.5x | E28.7% | n/a | Diversified Financials | ||
ALNY | US$232.27 | -17.0% | 40.5% | US$30.4b | US$301.21 | PS14.3x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
EH | US$15.39 | -8.8% | -1.5% | US$1.0b | US$24.35 | PS28.3x | E81.4% | n/a | Capital Goods | ||
SRPT | US$104.67 | -11.2% | 26.0% | US$10.0b | US$189.86 | PE82.1x | E42.6% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$140.15 | -3.5% | 178.0% | US$3.5t | US$160.38 | PE64.9x | E23.3% | 0.03% | Semiconductors | ||
CRDO | US$40.60 | -12.7% | 123.2% | US$6.6b | US$37.58 | PS31x | E95.0% | n/a | Semiconductors |